Management Madhumeha (Diabetes mellitus type 2)

Phase 2

• Conditions: Health Condition 1: E119- Type 2 diabetes mellitus without complications

• Registration Number: CTRI/2020/01/022662
• Lead Sponsor: Multani Pharmaceuticals Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 January 2023

Recruitment & Eligibility

• Status: Other (Terminated)
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Patients diagnosed for the first time or Diagnosed cases not taking any medicine for 3 last months.

2. Patients with cardinal symptoms of Madhumeha described in Ayurveda classics.

3. Patients having F.B.S. in the range of 126 â?? 200 mg/dl and/or P.P.B.S. between 180-300 mg/dl will be selected for the study.

4. Patients willing and able to provide signed ICF prior to study will be included in the study.

Exclusion Criteria

1. Patient with type 1 Diabetes mellitus.

2. Patients with type 2 Diabetes mellitus who are on insulin or oral hypoglycemic drugs.

3. Patients with FBS >= 200 mg/dl and/or PPBS >= 300 mg/dl.

4. Patients of Gestational Diabetes and Juvenile Diabetes.

5. Patient having Type-II DM with any other serious systemic disease.

6. Patients with complications like cardiac disorder, diabetic foot, Nephropathy and other secondary complications.

7. Diabetes Mellitus produced due to other illnesses like Acromegaly, Cushingâ??s syndrome, pancreatic disorders etc.

8. Individuals not willing to provide written Informed Consent Form.

9. Individuals participating in any other clinical trial.

10. Pregnant or lactating females.

Study & Design

• Study Type: Interventional
• Study Design: Not specified